Fibrosis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
SRRK | D | Scholar Rock Holding Corporation | 0.34 | |
GYRE | D | Gyre Therapeutics, Inc. | -1.85 | |
IVA | F | Inventiva S.A. | 0.00 | |
PLRX | F | Pliant Therapeutics, Inc. | 0.45 | |
MORF | F | Morphic Holding, Inc. | -1.60 | |
GLTO | F | Galecto, Inc. | 0.00 | |
ATNF | F | 180 Life Sciences Corp. | 0.00 | |
GRTX | F | Galera Therapeutics, Inc. | -2.25 |
Related Industries: Biotechnology Conglomerates
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 2.03 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 1.64 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 1.44 | |
XBI | D | SPDR S&P Biotech ETF | 1.36 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 0.81 |
Compare ETFs
- Fibrosis
Fibrosis is the formation of excess fibrous connective tissue in an organ or tissue in a reparative or reactive process. This can be a reactive, benign, or pathological state. In response to injury, this is called scarring, and if fibrosis arises from a single cell line, this is called a fibroma. Physiologically, fibrosis acts to deposit connective tissue, which can interfere with or totally inhibit the normal architecture and function of the underlying organ or tissue. Fibrosis can be used to describe the pathological state of excess deposition of fibrous tissue, as well as the process of connective tissue deposition in healing. Defined by the pathological accumulation of extracellular matrix (ECM) proteins, fibrosis results in scarring and thickening of the affected tissue, it is in essence an exaggerated wound healing response which interferes with normal organ function.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles